4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-010202
Options or other derivatives
- Director acquired 89,016 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
FORBES CHRISTOPHER · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-02-19 | Grant or award : show line 1 in the form Common Stock Option | +89,016 | $0.15 | 2018-02-19 | 89,016 | 1,495,821 | D |
Loading xslF345X03/form457955_20130220025836-.xml…